| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $3.9B | — | — | — | — |
| Op. Income | $732M | — | — | — | — |
| Gross Margin | 32.2% | — | — | — | — |
| Net Margin | 6.1% | — | — | — | — |
| EPS (Diluted) | $1.49 | — | — | — | — |
| Free Cash Flow | $0 | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $3.9B |
| Cost of Revenue | $2.6B |
| GROSS PROFIT | $1.3B |
| R&D Expenses | $97M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $421M |
| Other Expenses | $0 |
| Operating Expenses | $518M |
| Cost & Expenses | $3.2B |
| OPERATING INCOME | $732M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | -$85M |
| INCOME BEFORE TAX | $647M |
| Income Tax Expense | $362M |
| Net Income from Continuing Ops | $285M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $237M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $237M |
| D&A | $221M |
| EBIT | $732M |
| EBITDA | $953M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $3.9B |
| Cost of Revenue | $2.6B |
| GROSS PROFIT | $1.3B |
| R&D Expenses | $97M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $421M |
| Other Expenses | $0 |
| Operating Expenses | $518M |
| Cost & Expenses | $3.2B |
| OPERATING INCOME | $732M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | -$85M |
| INCOME BEFORE TAX | $647M |
| Income Tax Expense | $362M |
| Net Income from Continuing Ops | $285M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $237M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $237M |
| D&A | $221M |
| EBIT | $732M |
| EBITDA | $953M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $237M |
| Depreciation & Amortization | $220M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$457M |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $0 |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $0 |
| FREE CASH FLOW | $0 |
| Net Change in Cash | -$127M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $534M |
| Short-Term Investments | $0 |
| Net Receivables | $645M |
| Inventory | $715M |
| Other Current Assets | $494M |
| TOTAL CURRENT ASSETS | $2.4B |
| PP&E (Net) | $2.1B |
| Goodwill | $820M |
| Intangible Assets | $49M |
| Long-Term Investments | $162M |
| Tax Assets | $0 |
| Other Non-Current Assets | $199M |
| TOTAL NON-CURRENT ASSETS | $3.3B |
| TOTAL ASSETS | $5.7B |
| Account Payables | $909M |
| Short-Term Debt | $324M |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$1M |
| TOTAL CURRENT LIABILITIES | $1.7B |
| Long-Term Debt | $2.0B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $495M |
| TOTAL NON-CURRENT LIABILITIES | $2.6B |
| TOTAL LIABILITIES | $4.3B |
| Common Stock | $2M |
| Additional Paid-In Capital | $1.5B |
| Retained Earnings | $41M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$127M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.4B |
| Minority Interest | -$34M |
| TOTAL EQUITY | $1.4B |
| TOTAL LIABILITIES & EQUITY | $5.7B |
| Total Debt | $2.4B |
| Net Debt | $1.9B |
